» Articles » PMID: 27640676

Synchrotron Microbeam Irradiation Induces Neutrophil Infiltration, Thrombocyte Attachment and Selective Vascular Damage in Vivo

Overview
Journal Sci Rep
Specialty Science
Date 2016 Sep 20
PMID 27640676
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Our goal was the visualizing the vascular damage and acute inflammatory response to micro- and minibeam irradiation in vivo. Microbeam (MRT) and minibeam radiation therapies (MBRT) are tumor treatment approaches of potential clinical relevance, both consisting of parallel X-ray beams and allowing the delivery of thousands of Grays within tumors. We compared the effects of microbeams (25-100 μm wide) and minibeams (200-800 μm wide) on vasculature, inflammation and surrounding tissue changes during zebrafish caudal fin regeneration in vivo. Microbeam irradiation triggered an acute inflammatory response restricted to the regenerating tissue. Six hours post irradiation (6 hpi), it was infiltrated by neutrophils and fli1a(+) thrombocytes adhered to the cell wall locally in the beam path. The mature tissue was not affected by microbeam irradiation. In contrast, minibeam irradiation efficiently damaged the immature tissue at 6 hpi and damaged both the mature and immature tissue at 48 hpi. We demonstrate that vascular damage, inflammatory processes and cellular toxicity depend on the beam width and the stage of tissue maturation. Minibeam irradiation did not differentiate between mature and immature tissue. In contrast, all irradiation-induced effects of the microbeams were restricted to the rapidly growing immature tissue, indicating that microbeam irradiation could be a promising tumor treatment tool.

Citing Articles

Spatially fractionated minibeam radiation delivered at clinically feasible dose rates induces transient vascular permeability.

Fazzari J, Fernandez-Palomo C, Pellicioli P, Day L, Trappetti V, Lucien-Matteoni F Sci Rep. 2025; 15(1):8210.

PMID: 40064939 PMC: 11894116. DOI: 10.1038/s41598-025-87395-9.


MRT-boost as the last fraction may be the most efficient irradiation schedule for increased survival times in a rat glioma model.

Serduc R, Bouchet A J Synchrotron Radiat. 2023; 30(Pt 3):591-595.

PMID: 37067258 PMC: 10161883. DOI: 10.1107/S1600577523002606.


Targeted Accumulation of Macrophages Induced by Microbeam Irradiation in a Tissue-Dependent Manner.

Trappetti V, Fazzari J, Fernandez-Palomo C, Smyth L, Potez M, Shintani N Biomedicines. 2022; 10(4).

PMID: 35453485 PMC: 9025837. DOI: 10.3390/biomedicines10040735.


Radiobiological and Treatment-Related Aspects of Spatially Fractionated Radiotherapy.

Moghaddasi L, Reid P, Bezak E, Marcu L Int J Mol Sci. 2022; 23(6).

PMID: 35328787 PMC: 8954016. DOI: 10.3390/ijms23063366.


Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy.

Gomes E, Santiago Franco M Pharmaceutics. 2022; 14(1).

PMID: 35057001 PMC: 8781448. DOI: 10.3390/pharmaceutics14010105.


References
1.
Bouchet A, Boumendjel A, Khalil E, Serduc R, Brauer E, Siegbahn E . Chalcone JAI-51 improves efficacy of synchrotron microbeam radiation therapy of brain tumors. J Synchrotron Radiat. 2012; 19(Pt 4):478-82. DOI: 10.1107/S0909049512015105. View

2.
Miura M, Blattmann H, Brauer-Krisch E, Bravin A, Hanson A, Nawrocky M . Radiosurgical palliation of aggressive murine SCCVII squamous cell carcinomas using synchrotron-generated X-ray microbeams. Br J Radiol. 2006; 79(937):71-5. DOI: 10.1259/bjr/50464795. View

3.
Slatkin D, Spanne P, Dilmanian F, Sandborg M . Microbeam radiation therapy. Med Phys. 1992; 19(6):1395-400. DOI: 10.1118/1.596771. View

4.
Crosbie J, Anderson R, Rothkamm K, Restall C, Cann L, Ruwanpura S . Tumor cell response to synchrotron microbeam radiation therapy differs markedly from cells in normal tissues. Int J Radiat Oncol Biol Phys. 2010; 77(3):886-94. DOI: 10.1016/j.ijrobp.2010.01.035. View

5.
Poss K, Keating M, Nechiporuk A . Tales of regeneration in zebrafish. Dev Dyn. 2003; 226(2):202-10. DOI: 10.1002/dvdy.10220. View